O'Brien Greene & Co. Inc Abb Vie Inc. Transaction History

O'Brien Greene & Co. Inc

$305 Million
Q3 2024

A detailed history of O'Brien Greene & Co. Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 10,865 shares of ABBV stock, worth $1.92 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

10,865

Previous 12,261 11.39%

Holding current value

$1.92 Million

Previous $2.1 Million 2.0%

% of portfolio

0.7%

Previous 0.69%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$163.84 - $199.33 $228,720 - $278,264	-1,396 Reduced 11.39%	10,865 $2.15 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $1.14 Million - $1.33 Million	-7,337 Reduced 37.44%	12,261 $2.1 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $3,995 - $4,552	-25 Reduced 0.13%	19,598 $3.57 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $6,192 - $6,973	-45 Reduced 0.23%	19,623 $3.04 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $19,637 - $22,733	-147 Reduced 0.74%	19,668 $2.93 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $5.01 Million - $6.24 Million	-37,830 Reduced 65.63%	19,815 $2.67 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $5.03 Million - $6.26 Million	37,936 Added 192.48%	57,645 $7.77 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $3,615 - $4,163	-25 Reduced 0.13%	19,709 $3.14 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $5.66 Million - $6.79 Million	-40,956 Reduced 67.48%	19,734 $3.19 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $5.43 Million - $6.23 Million	40,464 Added 200.06%	60,690 $8.15 Million
Q1 2022 May 18, 2022	SELL	$131.98 - $163.75 $7,522 - $9,333	-57 Reduced 0.28%	20,226 $3.28 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $17,940 - $22,700	167 Added 0.83%	20,283 $2.75 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $7,980 - $9,058	75 Added 0.37%	20,116 $2.17 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $18,411 - $20,511	175 Added 0.88%	20,041 $2.26 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $479,156 - $646,912	5,953 Added 42.79%	19,866 $2.13 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $15,291 - $17,947	-178 Reduced 1.26%	13,913 $1.22 Million
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $2,201 - $2,945	-30 Reduced 0.21%	14,091 $1.38 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $10,642 - $16,135	-165 Reduced 1.15%	14,121 $1.08 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $169,505 - $212,087	-2,350 Reduced 14.13%	14,286 $1.27 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $3,149 - $3,786	-50 Reduced 0.3%	16,636 $1.26 Million
Q2 2019 Aug 21, 2019	SELL	$65.7 - $83.98 $26,082 - $33,340	-397 Reduced 2.32%	16,686 $1.21 Million
Q1 2019 Apr 29, 2019	BUY	$77.14 - $90.79 $156,208 - $183,849	2,025 Added 13.45%	17,083 $1.38 Million
Q4 2018 Feb 27, 2019	BUY	$77.85 - $96.01 $1.17 Million - $1.45 Million	15,058 New	15,058 $1.39 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Brien Greene & Co. Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Brien Greene & Co. Inc with notifications on news.

Account

O'Brien Greene & Co. Inc Abb Vie Inc. Transaction History